Rome, Italy

Antonello Mai

USPTO Granted Patents = 9 


Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1994-2019

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Antonello Mai: Innovator in Pharmaceutical Chemistry

Introduction

Antonello Mai is a prominent inventor based in Rome, Italy, known for his significant contributions to pharmaceutical chemistry. With a total of nine patents to his name, he has made remarkable strides in the development of innovative compounds aimed at treating various diseases, particularly cancer.

Latest Patents

Among his latest patents, one notable invention is the development of substituted quinazoline derivatives as DNA methyltransferase inhibitors. This invention relates to compounds that can be utilized as drugs in cancer treatment, along with their methods of preparation and pharmaceutical compositions. Another significant patent involves cyclopropylamine compounds as histone demethylase inhibitors. This disclosure pertains to cyclopropyl compounds and their therapeutic applications, including pharmaceutical compositions containing these compounds.

Career Highlights

Throughout his career, Antonello Mai has worked with several companies, including Dac S.r.l. and Repla Chemical Ltd. His work has been instrumental in advancing the field of medicinal chemistry, particularly in the area of drug development.

Collaborations

Antonello has collaborated with notable professionals in his field, including Silvio Massa and Saverio Minucci. These collaborations have further enriched his research and innovation efforts.

Conclusion

Antonello Mai's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in cancer treatment and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…